Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.

Puskás, László, Mán, Imola, Szebeni, Gábor, Tiszlavicz, László, Tsai, Susan, James, Michael A.: Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
MOLECULAR CANCER THERAPEUTICS, 15 (5). pp. 985-997. ISSN 1535-7163 (2016)

[img] Text
MCT_Tiszlavicz_2016_u.pdf - Published Version
Restricted access: Registered users only

Download (3MB) | Request a copy
Item Type: Article
Journal or Publication Title: MOLECULAR CANCER THERAPEUTICS
Date: 2016
Volume: 15
Number: 5
Page Range: pp. 985-997
ISSN: 1535-7163
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 3032869
DOI id: https://doi.org/10.1158/1535-7163.MCT-15-0717
Date Deposited: 2017. Jul. 27. 14:37
Last Modified: 2019. Dec. 05. 16:32
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11815
Web of Science® Times Cited: 7 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year